A first objective of this project is to establish an accurate topography of the SARS-CoV-2 virus in the organs and various cells
of patients who died in COVID-19 units, in order to contribute to a better understanding of the pathogenesis of COVID-19. A second
objective is to provide a routine diagnostic test for the detection of SARS-CoV-2 in routine samples in pathological anatomy.
DIAPath is particularly involved in the development of biomarkers (anti-SARS-Cov2 IHC, anti-ACE-2 IHC, anti-SARS-Cov-2 CISH).